|| Checking for direct PDF access through Ovid
The use of epidural catheters has been a subject of active debate in living liver donors because of the possible postoperative coagulation derangement and the subsequent risk of epidural hematoma. The aim of this study was to evaluate the safety of epidural catheters in relation to the changes in coagulation profile based on a review of previously published literature and the results of our 360 donors. In both the literature and in our cases, platelet count, prothrombin time (PT), and activated partial thromboplastin time (aPTT) in cases of heparin administration showed significant changes (P < 0.05), especially after right lobectomy. Platelet count reached its nadir on postoperative day (POD) 2–3, while PT and aPTT reached their peaks on POD 1–2 and at the end of the operation, respectively. In our donors, the ranges of platelet count, PT, and aPTT for the first 3 PODs were 54–359 ×10/μL, 0.99–2.38 international normalized ratio (INR), and 25.9–300 seconds, respectively, and of note, 5 donors (1.4%) had a platelet count of <80 × 10/μL and 9 donors (2.5%) had a PT of >2.0 INR. Epidural catheterizations were performed in 242 donors, and the catheters were removed on POD 3–4 in 177 donors (73.1%). Mean (range) of platelet count, PT, and aPTT on the day of catheter removal were 168.4 ± 42.9 (82–307) × 10/μL, 1.33 ± 0.18 (0.99–1.93) INR, and 40.9 ± 4.8 (32.0–70.6) seconds, respectively. No epidural hematoma was observed in this study. In conclusion, the discreet use of epidural catheters in live liver donors, in spite of postoperative coagulation derangements, appears to be safe regardless of the type of hepatectomy performed. Liver Transpl 13:62–70, 2007. © 2006 AASLD.